We are hiring!

Strain identifier

BacDive ID: 1743

Type strain: Yes

Species: Bifidobacterium longum subsp. infantis

Strain Designation: S12

Strain history: ATCC 15697 <-- G. Reuter S12.

For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 7 (current version):
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 2:
version 1:
version 7 (current version)

General

@ref: 8514

BacDive-ID: 1743

DSM-Number: 20088

keywords: mesophilic, anaerobe, Bacteria, 16S sequence, genome sequence

description: Bifidobacterium longum subsp. infantis S12 is an anaerobe, mesophilic bacterium that was isolated from intestine of infant.

NCBI tax id

NCBI tax idMatching level
1682subspecies
391904strain

strain history

doi: 10.13145/bacdive1743.20220920.7

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/actinomycetota
  • domain: Bacteria
  • phylum: Actinomycetota
  • class: Actinomycetes
  • order: Bifidobacteriales
  • family: Bifidobacteriaceae
  • genus: Bifidobacterium
  • species: Bifidobacterium longum subsp. infantis
  • full scientific name: Bifidobacterium longum subsp. infantis (Reuter 1963) Mattarelli et al. 2008
  • synonyms

    • @ref: 20215
    • synonym: Bifidobacterium infantis

@ref: 8514

domain: Bacteria

phylum: Actinobacteria

class: Actinobacteria

order: Bifidobacteriales

family: Bifidobacteriaceae

genus: Bifidobacterium

species: Bifidobacterium longum subsp. infantis

full scientific name: Bifidobacterium longum subsp. infantis (Reuter 1963) Mattarelli et al. 2008

strain designation: S12

type strain: yes

Culture and growth conditions

culture medium

@refnamegrowthlinkcomposition
8514BIFIDOBACTERIUM MEDIUM (DSMZ Medium 58)yeshttps://bacmedia.dsmz.de/medium/58Name: BIFIDOBACTERIUM MEDIUM (DSMZ Medium 58) Composition: Glucose 10.0 g/l Casein peptone 10.0 g/l Bacto Soytone 5.0 g/l Meat extract 5.0 g/l Yeast extract 5.0 g/l L-Cysteine HCl x H2O 0.5 g/l NaHCO3 0.4 g/l NaCl 0.08 g/l MnSO4 x H2O 0.05 g/l KH2PO4 0.04 g/l K2HPO4 0.04 g/l MgSO4 x 7 H2O 0.02 g/l CaCl2 x 2 H2O 0.01 g/l Tween 80 Resazurin Distilled water
37702MEDIUM 20 - for Anaerobic bacteriayesAgar (15.000 g);Glucose (5.000 g);Yeast extract (20.000 g);Tryptone (30.000 g);Cysteine hydrochloride (0.500 g);distilled water (1000.000 ml);Hemin solution -M00149 (25.000 ml)

culture temp

@refgrowthtypetemperaturerange
8514positivegrowth37mesophilic
37702positivegrowth37mesophilic
67770positivegrowth37mesophilic

Physiology and metabolism

oxygen tolerance

  • @ref: 8514
  • oxygen tolerance: anaerobe

murein

  • @ref: 8514
  • murein short key: A21.03
  • type: A3ß L-Orn-L-Ser-L-Ala-L-Thr-L-Ala

metabolite utilization

@refmetaboliteutilization activitykind of utilization testedChebi-ID
68371Potassium 5-ketogluconate-builds acid from
68371Potassium 2-ketogluconate-builds acid from
68371gluconate-builds acid from24265
68371L-arabitol-builds acid from18403
68371D-arabitol-builds acid from18333
68371L-fucose+builds acid from18287
68371D-fucose-builds acid from28847
68371D-tagatose-builds acid from16443
68371D-lyxose-builds acid from62318
68371turanose+builds acid from32528
68371gentiobiose-builds acid from28066
68371xylitol-builds acid from17151
68371starch-builds acid from28017
68371raffinose+builds acid from16634
68371melezitose-builds acid from6731
68371trehalose-builds acid from27082
68371sucrose+builds acid from17992
68371melibiose+builds acid from28053
68371lactose+builds acid from17716
68371maltose+builds acid from17306
68371cellobiose-builds acid from17057
68371amygdalin-builds acid from27613
68371methyl alpha-D-glucopyranoside+builds acid from320061
68371methyl alpha-D-mannoside-builds acid from43943
68371D-sorbitol-builds acid from17924
68371D-mannitol-builds acid from16899
68371myo-inositol-builds acid from17268
68371galactitol-builds acid from16813
68371L-rhamnose-builds acid from62345
68371L-sorbose-builds acid from17266
68371D-fructose+builds acid from15824
68371D-glucose+builds acid from17634
68371D-galactose+builds acid from12936
68371methyl beta-D-xylopyranoside-builds acid from74863
68371ribitol-builds acid from15963
68371L-xylose-builds acid from65328
68371D-xylose-builds acid from65327
68371D-ribose+builds acid from16988
68371L-arabinose-builds acid from30849
68371D-arabinose+builds acid from17108
68371erythritol-builds acid from17113
68371glycerol-builds acid from17754

API 50CHac

@refQGLYERYDARALARARIBDXYLLXYLADOMDXGALGLUFRUMNESBERHADULINOMANSORMDMMDGNAGAMYARBESCSALCELMALLACMELSACTREINUMLZRAFAMDGLYGXLTGENTURLYXTAGDFUCLFUCDARLLARLGNT2KG5KG
8514---+-+----++++-------++-+++-++++-+/--+----+---+-----
8514---+-+----++++-------+---++-++++---+----+---+-----
8514---+-+----+++--------+---+--++++---+----+---+-----
8514---+-+----++++-------++-+++-++++-+/--+----+---+-----
8514---+-+----++++-------++--++-++++-+-+-+--+---+-----
8514---+-+----++++-------++-++/-+-++++-+-+----+---+-----

Isolation, sampling and environmental information

isolation

@refsample type
8514intestine of infant
67770Intestine of infant

isolation source categories

Cat1Cat2Cat3
#Host#Human#Child
#Host Body-Site#Gastrointestinal tract

Safety information

risk assessment

  • @ref: 8514
  • biosafety level: 1
  • biosafety level comment: Risk group (German classification)

Sequence information

16S sequences

@refdescriptionaccessionlengthdatabaseNCBI tax ID
20218Bifidobacterium longum bv. Infantis gene for 16S rRNA, partial sequence, strain: ATCC 15697D861841515ena391904
20218Bifidobacterium longum subsp. infantis strain DSM 20088 16S ribosomal RNA gene, partial sequenceHQ012021940ena391904
20218Bifidobacterium infantis (ATCC 15697) 16S ribosomal RNA gene, partialM84783642ena1682
20218Bifidobacterium infantis ATCC 15697 16S-23S intergenic spacer, partial sequenceU09792477ena391904
20218B.infantis (CIP 6469) DNA sequence for 16S rRNAX709741458ena391904
20218Bifidobacterium sp. 16S and 23S rRNA genes and ITSX891112013ena391904
67770Bifidobacterium longum subsp. infantis gene for 16S ribosomal RNA, partial sequence, strain: JCM 1222LC0718201452ena391904
67770Bifidobacterium infantis 16S ribosomal RNAM587381474ena1682

Genome sequences

@refdescriptionaccessionassembly leveldatabaseNCBI tax ID
66792Bifidobacterium longum subsp. infantis NCTC11817GCA_900637215completencbi1682
66792Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088 ATCC 15697GCA_000020425completencbi391904
66792Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088 JCM 1222GCA_000269965completencbi391904
66792Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088 DSM 20088GCA_000771105contigncbi391904
66792Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222391904.5completepatric391904
66792Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222391904.8completepatric391904
66792Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088391904.20wgspatric391904
66792Bifidobacterium longum subsp. infantis strain NCTC118171682.48completepatric1682
66792Bifidobacterium longum infantis ATCC 15697643348516completeimg391904
66792Bifidobacterium longum infantis JCM 1222651053007completeimg391904
66792Bifidobacterium longum infantis ATCC 156972657245662draftimg391904
67770Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088 DNA, complete genomeAP010889ena391904
67770Bifidobacterium longum subsp. infantis ATCC 15697, complete genomeCP001095ena391904
67770Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088, whole genome shotgun sequencing projectJDTT00000000ncbi391904
67770Bifidobacterium longum subsp. infantis strain NCTC11817 genome assembly, chromosome: 1LR134354ena1682

GC content

@refGC-contentmethod
851460.8
6777060.8thermal denaturation, midpoint method (Tm)

External links

@ref: 8514

culture collection no.: DSM 20088, ATCC 15697, NCTC 11817, JCM 1222, BCRC 14602, BCRC 15416, CCM 4990, CCUG 18368, CECT 4551, CGMCC 1.1853, CGMCC 1.2202, CIP 64.67, KCTC 3249, KCTC 3270, LMG 8811, NCFB 2205

straininfo link

@refpassport
20218http://www.straininfo.net/strains/5495
20218http://www.straininfo.net/strains/5488
20218http://www.straininfo.net/strains/5500

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Pathogenicity2469742Current status of melanoma treatment with interferon, cytokines and other biologic response modifiers in Japan.Ishihara K, Hayasaka K, Yamazaki NJ Invest Dermatol10.1111/1523-1747.ep130767521989Biological Factors/administration & dosage/*therapeutic use, Biological Products/administration & dosage/*therapeutic use, Cell Wall Skeleton, Cytokines, DNA, Bacterial/administration & dosage/therapeutic use, Glycine/administration & dosage/analogs & derivatives/therapeutic use, Humans, Interferon Type I/administration & dosage/therapeutic use, Interferon-gamma/administration & dosage/therapeutic use, Interferons/administration & dosage/*therapeutic use, Interleukin-2/administration & dosage/therapeutic use, Leucine/administration & dosage/analogs & derivatives/therapeutic use, Male, Melanoma/*therapy, Middle Aged, Mucoproteins/administration & dosage/therapeutic use, Mycolic Acids/administration & dosage/therapeutic use, Picibanil/administration & dosage/therapeutic use, Recombinant Proteins, Skin Neoplasms/*therapy, Tumor Necrosis Factor-alpha/administration & dosage/therapeutic use
Phylogeny8550438Isolation and structural analysis of polysaccharide containing galactofuranose from the cell walls of Bifidobacterium infantis.Tone-Shimokawa Y, Toida T, Kawashima TJ Bacteriol10.1128/jb.178.1.317-320.19961996Bifidobacterium/*chemistry, Carbohydrate Sequence, Cell Wall/chemistry, Disaccharides/*analysis/chemistry, Galactans/chemistry, Galactose/*analysis/chemistry, Glucosamine/analysis, Glucose/analysis, Molecular Sequence Data, Muramic Acids/analysis, Polysaccharides, Bacterial/chemistry/*isolation & purificationGenetics
Pathogenicity8872711Growth characteristics of bifidobacteria in infant formulas.Dubey UK, Mistry VVJ Dairy Sci10.3168/jds.S0022-0302(96)76468-81996Acetic Acid/metabolism, Animals, Bifidobacterium/cytology/*growth & development, Buffers, Caseins, Fats/analysis, Humans, Hydrogen-Ion Concentration, Infant Food/analysis/*microbiology, Infant, Newborn, Kinetics, Lactic Acid/biosynthesis, Milk, Protein Hydrolysates, Proteins/analysis, SoybeansEnzymology
Pathogenicity8872712Effect of bifidogenic factors on growth characteristics of bifidobacteria in infant formulas.Dubey UK, Mistry VVJ Dairy Sci10.3168/jds.S0022-0302(96)76469-X1996Acetic Acid/metabolism, Bifidobacterium/*drug effects/*growth & development, Caseins, Colony Count, Microbial, Fructose/*pharmacology, Humans, Hydrogen-Ion Concentration, Infant, Infant Food/analysis/*microbiology, Lactic Acid/biosynthesis, Lactulose/*pharmacology, Oligosaccharides/*pharmacology, Protein Hydrolysates, SoybeansMetabolism
Metabolism9862646Mechanism of inhibition of tannic acid and related compounds on the growth of intestinal bacteria.Chung KT, Lu Z, Chou MWFood Chem Toxicol10.1016/s0278-6915(98)00086-61998Bacteria/*drug effects/growth & development/isolation & purification, Depression, Chemical, Gallic Acid/analogs & derivatives/metabolism/pharmacology, Humans, Hydrolyzable Tannins/analogs & derivatives/metabolism/*pharmacology, Intestines/*drug effects/microbiology, Iron/metabolism, Microbial Sensitivity Tests, Propyl Gallate/metabolism/pharmacology, Siderophores/metabolismPathogenicity
11028956Survival of bifidobacteria in yogurt and simulated gastric juice following immobilization in gellan-xanthan beads.Sun W, Griffiths MWInt J Food Microbiol10.1016/s0168-1605(00)00327-52000Bifidobacterium/*growth & development, Cells, Immobilized/physiology, Colony Count, Microbial, Food Additives, Gastric Juice/*microbiology, Hydrogen-Ion Concentration, Microspheres, *Polysaccharides, Bacterial, Time Factors, Yogurt/*microbiology
Enzymology11319112Intra- and extracellular beta-galactosidases from Bifidobacterium bifidum and B. infantis: molecular cloning, heterologous expression, and comparative characterization.Moller PL, Jorgensen F, Hansen OC, Madsen SM, Stougaard PAppl Environ Microbiol10.1128/AEM.67.5.2276-2283.20012001Amino Acid Sequence, Bifidobacterium/classification/*enzymology/genetics, Binding Sites/genetics, Escherichia coli/enzymology/genetics, Genes, Bacterial, Molecular Sequence Data, Recombinant Proteins/metabolism, Sequence Analysis, DNA, Substrate Specificity, *beta-Galactosidase/chemistry/genetics/isolation & purification/metabolismPhylogeny
Metabolism11412315Fermentations of fructo-oligosaccharides and their components by Bifidobacterium infantis ATCC 15697 on batch culture in semi-synthetic medium.Perrin S, Warchol M, Grill JP, Schneider FJ Appl Microbiol10.1046/j.1365-2672.2001.01317.x2001*Bacterial Proteins, Bacteriological Techniques, Bifidobacterium/*metabolism, Culture Media, Fermentation, Fructose/*metabolism, Glucose/metabolism, Glycoside Hydrolases/metabolism, Oligosaccharides/*metabolism, Sucrose/metabolismCultivation
Metabolism12200334Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut.Pereira DI, Gibson GRAppl Environ Microbiol10.1128/AEM.68.9.4689-4693.20022002Bifidobacterium/drug effects/growth & development/isolation & purification/*metabolism, Bile/metabolism, Cholesterol/*metabolism, Culture Media, Digestive System/*microbiology, Humans, Hydrochloric Acid/pharmacology, Lactic Acid/metabolism, Lactobacillus/drug effects/growth & development/isolation & purification/*metabolismPathogenicity
Enzymology12460425Characterization of a purified beta-fructofuranosidase from Bifidobacterium infantis ATCC 15697.Warchol M, Perrin S, Grill JP, Schneider FLett Appl Microbiol10.1046/j.1472-765x.2002.01224.x2002Bifidobacterium/*enzymology/growth & development, Electrophoresis, Polyacrylamide Gel, *Glycoside Hydrolases/chemistry/isolation & purification/metabolism, Hydrogen-Ion Concentration, Kinetics, Temperature, beta-FructofuranosidasePhylogeny
Pathogenicity12650667Growth inhibition of intestinal bacteria and mutagenicity of 2-, 3-, 4-aminobiphenyls, benzidine, and biphenyl.Chung KT, Adris PToxicol In Vitro10.1016/s0887-2333(02)00131-52003Aminobiphenyl Compounds/*toxicity, Benzidines/*toxicity, Biphenyl Compounds/*toxicity, Gram-Negative Bacteria/drug effects/growth & development, Gram-Positive Bacteria/drug effects/growth & development, Humans, Intestines/*microbiology, Mutagenicity Tests, Mutagens/*toxicity
Metabolism17462768Myo-inositol hexakisphosphate degradation by Bifidobacterium infantis ATCC 15697.Haros M, Bielecka M, Honke J, Sanz YInt J Food Microbiol10.1016/j.ijfoodmicro.2007.02.02120076-Phytase/metabolism, Bifidobacterium/*enzymology/growth & development/metabolism, *Food Microbiology, Hydrogen-Ion Concentration, Inositol Phosphates/*metabolism, Kinetics, Phytic Acid/metabolism, *Probiotics, TemperatureEnzymology
Phylogeny18398167Proposal to reclassify the three biotypes of Bifidobacterium longum as three subspecies: Bifidobacterium longum subsp. longum subsp. nov., Bifidobacterium longum subsp. infantis comb. nov. and Bifidobacterium longum subsp. suis comb. nov.Mattarelli P, Bonaparte C, Pot B, Biavati BInt J Syst Evol Microbiol10.1099/ijs.0.65319-02008Bacterial Proteins/genetics, Bacterial Typing Techniques, Bifidobacterium/*classification/*genetics/metabolism, Carbohydrate Metabolism, Chaperonin 60/genetics, DNA, Bacterial/genetics, Fermentation, Genes, Bacterial, Genotype, Nucleic Acid Hybridization, Phenotype, Plasmids/genetics, Polymerase Chain Reaction, RNA, Bacterial/genetics, RNA, Ribosomal, 16S/genetics, Ribotyping, Species Specificity, Terminology as TopicMetabolism
Genetics19033196The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome.Sela DA, Chapman J, Adeuya A, Kim JH, Chen F, Whitehead TR, Lapidus A, Rokhsar DS, Lebrilla CB, German JB, Price NP, Richardson PM, Mills DAProc Natl Acad Sci U S A10.1073/pnas.08095841052008Bacterial Proteins/classification/genetics/metabolism, Bifidobacterium/*genetics/metabolism, Breast Feeding, Female, Gastrointestinal Tract/*microbiology, Genome, Bacterial, Humans, Infant, Newborn, *Milk, Human/chemistry/metabolism, Molecular Sequence Data, Multigene Family, Oligosaccharides/chemistry/metabolism, Phylogeny, PregnancyMetabolism
Metabolism20802066Broad conservation of milk utilization genes in Bifidobacterium longum subsp. infantis as revealed by comparative genomic hybridization.LoCascio RG, Desai P, Sela DA, Weimer B, Mills DAAppl Environ Microbiol10.1128/AEM.00675-102010Bifidobacterium/*genetics/metabolism, Comparative Genomic Hybridization, DNA, Bacterial/*genetics, *Genes, Bacterial, Genotype, Humans, Metabolic Networks and Pathways/*genetics, Milk, Human/*metabolism, Molecular Sequence Data, Multigene Family, Multilocus Sequence Typing, Oligosaccharides/*metabolism, Phylogeny, Sequence Analysis, DNA, Urea/metabolismGenetics
Metabolism21799473Substrate promiscuity of N-acetylhexosamine 1-kinases.Li Y, Yu H, Chen Y, Lau K, Cai L, Cao H, Tiwari VK, Qu J, Thon V, Wang PG, Chen XMolecules10.3390/molecules160863962011*Acetylgalactosamine/analogs & derivatives/metabolism, *Acetylglucosamine/analogs & derivatives/metabolism, Adenosine Triphosphate/metabolism, Amino Acid Sequence, Bifidobacterium/*enzymology/genetics, Carbohydrate Conformation, Cloning, Molecular, Electrophoresis, Capillary, Electrophoresis, Polyacrylamide Gel, Escherichia coli, Galactose/metabolism, Glucose/metabolism, Hydrogen-Ion Concentration, Isoenzymes/genetics/*metabolism, Kinetics, Mannose/metabolism, Molecular Sequence Data, Phosphates/metabolism, Phosphotransferases/genetics/*metabolism, Plasmids, Protein Engineering/*methods, Recombinant Proteins/genetics/*metabolism, Substrate Specificity, Transformation, BacterialEnzymology
Metabolism21832085Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria.Asakuma S, Hatakeyama E, Urashima T, Yoshida E, Katayama T, Yamamoto K, Kumagai H, Ashida H, Hirose J, Kitaoka MJ Biol Chem10.1074/jbc.M111.2481382011Adult, Bifidobacteriales Infections/microbiology, Bifidobacterium/*metabolism, Carbohydrates/chemistry, Chromatography, High Pressure Liquid/methods, Female, Gastrointestinal Tract/microbiology, Humans, Infant, Newborn, Intestines/*microbiology, Japan, Milk, Human/*metabolism, Molecular Sequence Data, Monosaccharides, Oligosaccharides/chemistry/*metabolism, Time FactorsPathogenicity
Enzymology22138995Bifidobacterium longum subsp. infantis ATCC 15697 alpha-fucosidases are active on fucosylated human milk oligosaccharides.Sela DA, Garrido D, Lerno L, Wu S, Tan K, Eom HJ, Joachimiak A, Lebrilla CB, Mills DAAppl Environ Microbiol10.1128/AEM.06762-112011Bifidobacterium/chemistry/*enzymology/genetics/metabolism, Crystallography, X-Ray, Fermentation, Gene Expression Profiling, Genes, Bacterial, Humans, Kinetics, Milk, Human/*chemistry, Models, Molecular, Multigene Family, Oligosaccharides/*metabolism, Phylogeny, Protein Structure, Tertiary, Sequence Homology, Amino Acid, alpha-L-Fucosidase/chemistry/genetics/*metabolismMetabolism
Metabolism22579845Release and utilization of N-acetyl-D-glucosamine from human milk oligosaccharides by Bifidobacterium longum subsp. infantis.Garrido D, Ruiz-Moyano S, Mills DAAnaerobe10.1016/j.anaerobe.2012.04.0122012Acetylglucosamine/*metabolism, Bifidobacterium/*enzymology/genetics/growth & development, Chromatography, Thin Layer, Cloning, Molecular, Enzyme Activation, Gene Expression Regulation, Bacterial, Gene Expression Regulation, Enzymologic, Genome, Bacterial, Humans, Hydrogen-Ion Concentration, Milk, Human/*chemistry, Oligosaccharides/*metabolism, Substrate Specificity, Uridine Diphosphate N-Acetylglucosamine/metabolism, beta-N-Acetylhexosaminidases/genetics/metabolismEnzymology
Metabolism22582052Novel phytases from Bifidobacterium pseudocatenulatum ATCC 27919 and Bifidobacterium longum subsp. infantis ATCC 15697.Tamayo-Ramos JA, Sanz-Penella JM, Yebra MJ, Monedero V, Haros MAppl Environ Microbiol10.1128/AEM.00782-1220126-Phytase/*genetics/metabolism, Bacterial Proteins/genetics/metabolism, Bifidobacterium/*classification/*enzymology/genetics, Humans, Hydrogen-Ion Concentration, Hydrolysis, Phytic Acid/*metabolism, Polymerase Chain Reaction, *Probiotics, Substrate Specificity, TemperaturePathogenicity
Enzymology22633137A highly efficient galactokinase from Bifidobacterium infantis with broad substrate specificity.Li L, Liu Y, Wang W, Cheng J, Zhao W, Wang PCarbohydr Res10.1016/j.carres.2012.04.0222012Bifidobacterium/*enzymology, Galactokinase/isolation & purification/*metabolism, Galactosephosphates/biosynthesis/chemistry/metabolism, Recombinant Proteins/isolation & purification/metabolism, Substrate SpecificityMetabolism
Pathogenicity22897719Identification and accurate quantitation of biological oligosaccharide mixtures.Strum JS, Kim J, Wu S, De Leoz ML, Peacock K, Grimm R, German JB, Mills DA, Lebrilla CBAnal Chem10.1021/ac301128s2012Bifidobacterium/enzymology, *Chromatography, High Pressure Liquid, Deuterium Exchange Measurement, Gastrointestinal Tract/microbiology, Glycoside Hydrolases/metabolism, Humans, *Mass Spectrometry, Milk, Human/chemistry, Oligosaccharides/*analysisEnzymology
Metabolism23200660Utilization of galactooligosaccharides by Bifidobacterium longum subsp. infantis isolates.Garrido D, Ruiz-Moyano S, Jimenez-Espinoza R, Eom HJ, Block DE, Mills DAFood Microbiol10.1016/j.fm.2012.10.0032012Bacterial Proteins/genetics/metabolism, Bifidobacterium/enzymology/genetics/*metabolism, Gastrointestinal Tract/microbiology, Humans, Oligosaccharides/*metabolism, Prebiotics/analysis, beta-Galactosidase/genetics/metabolismPathogenicity
Phylogeny23315725Isolation of a bifidogenic peptide from the pepsin hydrolysate of bovine lactoferrin.Oda H, Wakabayashi H, Yamauchi K, Sato T, Xiao JZ, Abe F, Iwatsuki KAppl Environ Microbiol10.1128/AEM.03343-122013Animals, Bifidobacterium/*drug effects/*growth & development, Cattle, Growth Inhibitors/*isolation & purification/pharmacology, Hydrolysis, Intercellular Signaling Peptides and Proteins/*isolation & purification/pharmacology, Lactoferrin/*metabolism, Microbial Sensitivity Tests, Pepsin A/*metabolismEnzymology
Metabolism23332852Antimicrobial potential for the combination of bovine lactoferrin or its hydrolysate with lactoferrin-resistant probiotics against foodborne pathogens.Chen PW, Jheng TT, Shyu CL, Mao FCJ Dairy Sci10.3168/jds.2012-61122013Animals, Anti-Infective Agents/administration & dosage/*therapeutic use, Bifidobacterium/metabolism, Cattle, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Lactobacillus/metabolism, Lactobacillus acidophilus/metabolism, Lactobacillus rhamnosus/metabolism, Lactoferrin/administration & dosage/drug effects/*therapeutic use, Pediococcus/metabolism, Probiotics/administration & dosage/*therapeutic use, Protein Hydrolysates, Salmonella typhimurium/drug effectsPathogenicity
Pathogenicity23805302Exposure of Bifidobacterium longum subsp. infantis to Milk Oligosaccharides Increases Adhesion to Epithelial Cells and Induces a Substantial Transcriptional Response.Kavanaugh DW, O'Callaghan J, Butto LF, Slattery H, Lane J, Clyne M, Kane M, Joshi L, Hickey RMPLoS One10.1371/journal.pone.00672242013Animals, Bacterial Adhesion/*drug effects/physiology, Bifidobacterium longum subspecies infantis/*metabolism, Caco-2 Cells, Humans, *Intestinal Mucosa/metabolism/microbiology, *Milk, Oligonucleotide Array Sequence Analysis, Oligosaccharides/metabolism/*pharmacokinetics, *Transcription, GeneticMetabolism
Enzymology24124888Enrichment of Bifidobacterium longum subsp. infantis ATCC 15697 within the human gut microbiota using alginate-poly-L-lysine-alginate microencapsulation oral delivery system: an in vitro analysis using a computer-controlled dynamic human gastrointestinal model.Rodes L, Tomaro-Duchesneau C, Saha S, Paul A, Malhotra M, Marinescu D, Shao W, Kahouli I, Prakash SJ Microencapsul10.3109/02652048.2013.8349902013Administration, Oral, *Alginates/chemistry/pharmacokinetics/pharmacology, *Bifidobacterium, Capsules, *Computer Simulation, Humans, Intestines/*microbiology, *Microbiota, *Models, Biological, Polylysine/*analogs & derivatives/chemistry/pharmacokinetics/pharmacology, Stomach/*microbiologyPathogenicity
Metabolism24255712Bifidobacterium longum alleviates dextran sulfate sodium-induced colitis by suppressing IL-17A response: involvement of intestinal epithelial costimulatory molecules.Miyauchi E, Ogita T, Miyamoto J, Kawamoto S, Morita H, Ohno H, Suzuki T, Tanabe SPLoS One10.1371/journal.pone.00797352013Animals, B7-1 Antigen/genetics/metabolism, B7-2 Antigen/genetics/metabolism, Bifidobacterium/*metabolism, CD40 Antigens/genetics/metabolism, Colitis/chemically induced/genetics/immunology/*metabolism/microbiology, Cytokines/metabolism, Dextran Sulfate/adverse effects, Female, Gene Expression Regulation, Interleukin-17/*metabolism, Intestinal Mucosa/immunology/metabolism/pathology, Mice, Th17 Cells/immunology/metabolism, Transcription Factors/genetics/metabolism
Metabolism24270321Distinct substrate specificities of three glycoside hydrolase family 42 beta-galactosidases from Bifidobacterium longum subsp. infantis ATCC 15697.Viborg AH, Katayama T, Abou Hachem M, Andersen MC, Nishimoto M, Clausen MH, Urashima T, Svensson B, Kitaoka MGlycobiology10.1093/glycob/cwt1042013Amino Acid Sequence, Bifidobacterium/*enzymology/genetics/metabolism, Galactans/metabolism, Galactose/metabolism, Galactosides/metabolism, Glycoside Hydrolases/chemistry/genetics/*metabolism, Models, Molecular, Molecular Sequence Data, Multigene Family, Phylogeny, Substrate Specificity, beta-Galactosidase/chemistry/genetics/*metabolismGenetics
Pathogenicity24967382Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats.Rodes L, Saha S, Tomaro-Duchesneau C, Prakash SBiomed Res Int10.1155/2014/6028322014Animals, *Bifidobacterium, Colon/*metabolism/*microbiology, Endotoxemia/blood/microbiology/therapy, Endotoxins/*blood, Humans, Male, *Microbiota, Rats, Rats, Inbred F344Metabolism
Metabolism25435500Multi-functional glycoside hydrolase: Blon_0625 from Bifidobacterium longum subsp. infantis ATCC 15697.Matsumoto T, Shimada S, Hata Y, Tanaka T, Kondo AEnzyme Microb Technol10.1016/j.enzmictec.2014.10.0012014Actinobacteria/enzymology/genetics, Alteromonadaceae/enzymology/genetics, Bacterial Proteins/genetics/*isolation & purification/metabolism, Bifidobacterium/*enzymology/genetics, Biodegradation, Environmental, Cellobiose/metabolism, Disaccharides/metabolism, Gene Expression Regulation, Bacterial, Genes, Bacterial, Glycoside Hydrolases/genetics/*isolation & purification/metabolism, Hydrolysis, Lignin/metabolism, Oligosaccharides/metabolism, Recombinant Fusion Proteins/metabolism, Substrate SpecificityEnzymology
Pathogenicity25794720Enzymatic production of HMO mimics by the sialylation of galacto-oligosaccharides.Wang Y, Jiang K, Ma H, Zeng W, Wang PG, Yao N, Han W, Cheng J, Wang WFood Chem10.1016/j.foodchem.2015.02.0642015Health Maintenance Organizations, Humans, Milk, Human, Oligosaccharides/*chemistry, Polysaccharides/*chemistry, PrebioticsBiotechnology
Enzymology25942062Comparing substrate specificity of two UDP-sugar pyrophosphorylases and efficient one-pot enzymatic synthesis of UDP-GlcA and UDP-GalA.Guo Y, Fang J, Li T, Li X, Ma C, Wang X, Wang PG, Li LCarbohydr Res10.1016/j.carres.2015.04.0012015Arabidopsis/enzymology, Arabidopsis Proteins/*chemistry, Bacterial Proteins/*chemistry, Bifidobacterium/enzymology, Biocatalysis, Kinetics, Nucleotidyltransferases/*chemistry, Substrate Specificity, Uridine Diphosphate Glucuronic Acid/*chemistry, Uridine Diphosphate Sugars/*chemistry
Enzymology26101185A novel endo-beta-N-acetylglucosaminidase releases specific N-glycans depending on different reaction conditions.Parc AL, Karav S, De Moura Bell JMLN, Frese SA, Liu Y, Mills DA, Block DE, Barile DBiotechnol Prog10.1002/btpr.21332015Animals, Bifidobacterium/enzymology, Cattle, Chemical Phenomena, Colostrum, Glycoproteins/chemistry, Glycosylation, Hydrogen-Ion Concentration, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase/*metabolism, Milk Proteins/chemistry, Pilot Projects, Polysaccharides/*chemistry, TemperatureMetabolism
Enzymology26210151Functional analysis of the type II toxin-antitoxin systems of the MazEF and RelBE families in Bifidobacterium longum subsp. infantis ATCC 15697.Averina O, Alekseeva M, Shkoporov A, Danilenko VAnaerobe10.1016/j.anaerobe.2015.07.0072015Bacterial Toxins/*genetics, Bifidobacterium/*genetics/growth & development, Cloning, Molecular, Escherichia coli/genetics/physiology, Gene Expression Profiling, Microbial Viability, *OperonPathogenicity
Metabolism26337101Comparative transcriptomics reveals key differences in the response to milk oligosaccharides of infant gut-associated bifidobacteria.Garrido D, Ruiz-Moyano S, Lemay DG, Sela DA, German JB, Mills DASci Rep10.1038/srep135172015Animals, Bifidobacterium/*metabolism, Gastrointestinal Microbiome/physiology, Humans, Intestinal Mucosa/*metabolism, Intestines/*microbiology, Milk, Human/*chemistry/microbiology, Oligosaccharides/*metabolism, Transcription Factors/*metabolism, Transcriptome/physiologyPathogenicity
Pathogenicity26689225Interaction of mouse splenocytes and macrophages with bacterial strains in vitro: the effect of age in the immune response.Van Beek AA, Hoogerland JA, Belzer C, De Vos P, De Vos WM, Savelkoul HF, Leenen PJBenef Microbes10.3920/BM2015.00942015Age Factors, Aging/drug effects/*immunology, Animals, Bifidobacterium/*physiology, Humans, Interleukin-10/immunology, Interleukin-6/immunology, Lactobacillus/*physiology, Macrophages/drug effects/*immunology, Male, Mice, Mice, Inbred C57BL, Probiotics/*pharmacology, Spleen/cytology/drug effects/*immunology, Tumor Necrosis Factor-alpha/immunology
Phylogeny26823373Bifidobacterium eulemuris sp. nov., isolated from faeces of black lemurs (Eulemur macaco).Michelini S, Modesto M, Pisi AM, Filippini G, Sandri C, Spiezio C, Biavati B, Sgorbati B, Mattarelli PInt J Syst Evol Microbiol10.1099/ijsem.0.0009242016
Metabolism26859770Deciphering bifidobacterial-mediated metabolic interactions and their impact on gut microbiota by a multi-omics approach.Turroni F, Milani C, Duranti S, Mancabelli L, Mangifesta M, Viappiani A, Lugli GA, Ferrario C, Gioiosa L, Ferrarini A, Li J, Palanza P, Delledonne M, van Sinderen D, Ventura MISME J10.1038/ismej.2015.2362016Bifidobacterium/*metabolism/physiology, Carbohydrate Metabolism, Fatty Acids, Volatile/metabolism, *Gastrointestinal Microbiome, Humans, Intestines/microbiology, Polysaccharides/metabolism, Starch/metabolismPathogenicity
Metabolism27084007Oligosaccharides Released from Milk Glycoproteins Are Selective Growth Substrates for Infant-Associated Bifidobacteria.Karav S, Le Parc A, Leite Nobrega de Moura Bell JM, Frese SA, Kirmiz N, Block DE, Barile D, Mills DAAppl Environ Microbiol10.1128/AEM.00547-162016Animals, Bifidobacterium/*enzymology/growth & development/*metabolism, Glycoproteins/*metabolism, Humans, Infant, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase/*metabolism, Milk/*metabolism, Oligosaccharides/*metabolismPathogenicity
Metabolism27086652Functional characterization of a novel beta-fructofuranosidase from Bifidobacterium longum subsp. infantis ATCC 15697 on structurally diverse fructans.Avila-Fernandez A, Cuevas-Juarez E, Rodriguez-Alegria ME, Olvera C, Lopez-Munguia AJ Appl Microbiol10.1111/jam.131542016Bacterial Proteins/chemistry/genetics/*metabolism, Bifidobacterium longum subspecies infantis/*enzymology/genetics/metabolism, Fructans/*chemistry/*metabolism, Molecular Weight, Oligosaccharides/chemistry/metabolism, Substrate Specificity, Sucrose/metabolism, beta-Fructofuranosidase/chemistry/genetics/*metabolismEnzymology
Enzymology27718339Recent advances in immobilization strategies for glycosidases.Karav S, Cohen JL, Barile D, de Moura Bell JMBiotechnol Prog10.1002/btpr.23852016Bifidobacterium longum/enzymology, Enzymes, Immobilized/*chemistry, Glycoside Hydrolases/*chemistry/metabolism, Glycosylation, Mannose/chemistry, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase/*chemistry/metabolism, Polysaccharides/*chemistry, Protein FoldingMetabolism
Metabolism28780103Human milk oligosaccharide consumption by probiotic and human-associated bifidobacteria and lactobacilli.Thongaram T, Hoeflinger JL, Chow J, Miller MJJ Dairy Sci10.3168/jds.2017-127532017Animals, Bifidobacterium/*metabolism, Humans, Lactobacillus/*metabolism, Milk, Human/*chemistry, Oligosaccharides/*metabolism, Probiotics/metabolismPathogenicity
Biotechnology30018849Use of design of experiments to optimize the production of microbial probiotic biofilms.Speranza B, Liso A, Corbo MRPeerJ10.7717/peerj.48262018
30513877Mining Milk for Factors which Increase the Adherence of Bifidobacterium longum subsp. infantis to Intestinal Cells.Quinn EM, Slattery H, Thompson AP, Kilcoyne M, Joshi L, Hickey RMFoods10.3390/foods71201962018
Genetics30927646Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients.Rong H, Xie XH, Zhao J, Lai WT, Wang MB, Xu D, Liu YH, Guo YY, Xu SX, Deng WF, Yang QF, Xiao L, Zhang YL, He FS, Wang S, Liu TBJ Psychiatr Res10.1016/j.jpsychires.2019.03.0172019Adult, Bipolar Disorder/*microbiology, Depressive Disorder, Major/*microbiology, Feces/microbiology, Female, Gastrointestinal Microbiome/*physiology, Humans, Male, Metagenomics/*methods/statistics & numerical dataPathogenicity
Metabolism31747272Structural Identity of Galactooligosaccharide Molecules Selectively Utilized by Single Cultures of Probiotic Bacterial Strains.Boger M, van Leeuwen SS, Lammerts van Bueren A, Dijkhuizen LJ Agric Food Chem10.1021/acs.jafc.9b059682019Bifidobacterium/growth & development/*metabolism, Lactobacillus/growth & development/*metabolism, Lactobacillus acidophilus/growth & development/metabolism, Oligosaccharides/*chemistry/*metabolism, Prebiotics/analysis, Probiotics/metabolism
32192119Bifidobacterium longum subsp. infantis ATCC 15697 and Goat Milk Oligosaccharides Show Synergism In Vitro as Anti-Infectives against Campylobacter jejuni.Quinn EM, Slattery H, Walsh D, Joshi L, Hickey RMFoods10.3390/foods90303482020
Pathogenicity32610704A Whey Fraction Rich in Immunoglobulin G Combined with Bifidobacterium longum subsp. infantis ATCC 15697 Exhibits Synergistic Effects against Campylobacter jejuni.Quinn EM, Kilcoyne M, Walsh D, Joshi L, Hickey RMInt J Mol Sci10.3390/ijms211346322020Bifidobacterium/growth & development, Bifidobacterium longum subspecies infantis/*drug effects/genetics/metabolism, Campylobacter jejuni/*drug effects/genetics, DNA, Bacterial/genetics, HT29 Cells, Humans, Immunoglobulin G/metabolism, Intestines/microbiology, Microbiota/genetics, Whey/*chemistry/metabolism, Whey Proteins/metabolism/*pharmacologyMetabolism
Metabolism32985563Strain-specific strategies of 2'-fucosyllactose, 3-fucosyllactose, and difucosyllactose assimilation by Bifidobacterium longum subsp. infantis Bi-26 and ATCC 15697.Zabel BE, Gerdes S, Evans KC, Nedveck D, Singles SK, Volk B, Budinoff CSci Rep10.1038/s41598-020-72792-z2020Bifidobacterium longum/*metabolism, Gastrointestinal Tract/*microbiology, Humans, Infant, Oligosaccharides/*metabolism, Species Specificity, Trisaccharides/*metabolismPathogenicity
Biotechnology33042083Riboflavin Biosynthesis and Overproduction by a Derivative of the Human Gut Commensal Bifidobacterium longum subsp. infantis ATCC 15697.Solopova A, Bottacini F, Venturi Degli Esposti E, Amaretti A, Raimondi S, Rossi M, van Sinderen DFront Microbiol10.3389/fmicb.2020.5733352020
Phylogeny33226935Five novel bifidobacterial species isolated from faeces of primates in two Czech zoos: Bifidobacterium erythrocebi sp. nov., Bifidobacterium moraviense sp. nov., Bifidobacterium oedipodis sp. nov., Bifidobacterium olomucense sp. nov. and Bifidobacterium panos sp. nov.Neuzil-Bunesova V, Lugli GA, Modrackova N, Vlkova E, Bolechova P, Burtscher J, Longhi G, Mancabelli L, Killer J, Domig K, Ventura MInt J Syst Evol Microbiol10.1099/ijsem.0.0045732020Animals, Animals, Zoo/microbiology, Bacterial Typing Techniques, Base Composition, Bifidobacterium/*classification/isolation & purification, Czech Republic, DNA, Bacterial/genetics, Fatty Acids/chemistry, Feces/*microbiology, Nucleic Acid Hybridization, *Phylogeny, Primates/*microbiology, RNA, Ribosomal, 16S/genetics, Sequence Analysis, DNATranscriptome
Metabolism33460787Generating a fucose permease deletion mutant in Bifidobacterium longum subspecies infantis ATCC 15697.Higgins MA, Ryan KSAnaerobe10.1016/j.anaerobe.2021.1023202021Bacterial Proteins/*genetics/metabolism, Bifidobacterium longum subspecies infantis/*enzymology/genetics/metabolism, Fucose/*metabolism, Gene Deletion, Membrane Transport Proteins/*genetics/metabolismEnzymology
33579683A postbiotic consisting of heat-treated lactobacilli has a bifidogenic effect in pure culture and in human fermented faecal communities.Warda AK, Clooney AG, Ryan F, de Almeida Bettio PH, Di Benedetto G, Ross RP, Hill CAppl Environ Microbiol10.1128/AEM.02459-202021
Metabolism344296961,6-alpha-L-Fucosidases from Bifidobacterium longum subsp. infantis ATCC 15697 Involved in the Degradation of Core-fucosylated N -Glycan.Ashida H, Fujimoto T, Kurihara S, Nakamura M, Komeno M, Huang Y, Katayama T, Kinoshita T, Takegawa KJ Appl Glycosci (1999)10.5458/jag.jag.JAG-2019_00162020
Pathogenicity34553672Next-generation prebiotic promotes selective growth of bifidobacteria, suppressing Clostridioides difficile.Hirano R, Sakanaka M, Yoshimi K, Sugimoto N, Eguchi S, Yamauchi Y, Nara M, Maeda S, Ami Y, Gotoh A, Katayama T, Iida N, Kato T, Ohno H, Fukiya S, Yokota A, Nishimoto M, Kitaoka M, Nakai H, Kurihara SGut Microbes10.1080/19490976.2021.19738352021ATP-Binding Cassette Transporters/metabolism, Animals, Bifidobacterium/genetics/*growth & development, Bifidobacterium longum subspecies infantis/genetics/*growth & development, Clostridioides difficile/*growth & development, Disaccharides/*pharmacology, Gastrointestinal Microbiome/drug effects, Humans, Intestines/microbiology, Male, Mice, Mice, Inbred C57BL, Prebiotics/*analysisMetabolism
Phylogeny35208658Phylogenetic, Functional and Safety Features of 1950s B. infantis Strains.Duboux S, Ngom-Bru C, De Bruyn F, Bogicevic BMicroorganisms10.3390/microorganisms100202032022
Pathogenicity35219990The mechanism of probiotic action of human milk N-glycome towards B. infantis ATCC 15697 and identification of the principal functional components.Mao H, Li S, Yin B, Lin X, Guo J, Wang T, Voglmeir J, Liu LFood Chem10.1016/j.foodchem.2022.1325322022Bifidobacterium longum subspecies infantis, Humans, *Milk, Human, Oligosaccharides, Polysaccharides, *Probiotics

Reference

@idauthorscataloguedoi/urltitlejournalpubmed
8514Curators of the DSMZLeibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 20088)https://www.dsmz.de/collection/catalogue/details/culture/DSM-20088
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.10.1099/ijsem.0.004332List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
20218Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.10.1016/j.syapm.2013.11.002StrainInfo introduces electronic passports for microorganisms.Syst Appl Microbiol. 37: 42-50 201424321274
37702Curators of the CIPhttps://brclims.pasteur.fr/brcWeb/souche/detail/1/10172
66792Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesAutomatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
67770Curators of the JCMhttps://jcm.brc.riken.jp/en/
68371Automatically annotated from API 50CH acid